dichloroacetic acid has been researched along with tanespimycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allende-Vega, N; Bertolini, F; Cartron, G; Hicheri, Y; Krzywinska, E; Lopez-Royuela, N; Orecchioni, S; Reggiani, F; Rossi, JF; Rossignol, R; Talarico, G; Villalba, M | 1 |
| Allende-Vega, N; Villalba, M | 1 |
2 other study(ies) available for dichloroacetic acid and tanespimycin
| Article | Year |
|---|---|
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Cell Cycle Checkpoints; Cell Line, Tumor; Dichloroacetic Acid; Doxorubicin; Drug Synergism; HCT116 Cells; HL-60 Cells; Humans; Lactams, Macrocyclic; Leukemia; Mice; Oxidative Phosphorylation; Transcription, Genetic; Tumor Suppressor Protein p53 | 2015 |
Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells.
Topics: Antineoplastic Agents; Autophagy; Benzoquinones; Cell Line, Tumor; Dichloroacetic Acid; Humans; Lactams, Macrocyclic; Leukemia, Myeloid, Acute; Mutation; Stress, Physiological; Tumor Suppressor Protein p53 | 2019 |